Safety profile of uncrossmatched, cold‐stored, low‐titer, group O+ whole blood in civilian trauma patients
暂无分享,去创建一个
J. Sperry | D. Triulzi | M. Yazer | J. Seheult | Vincent P. Anto | L. Alarcon | A. Corcos | M. Bahr
[1] D. Triulzi,et al. How do I implement a whole blood program for massively bleeding patients? , 2018, Transfusion.
[2] S. Kleinman,et al. Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO‐incompatible plasma , 2018, Transfusion.
[3] M. Yazer,et al. Safety of the use of group A plasma in trauma: the STAT study , 2017, Transfusion.
[4] J. Sperry,et al. Measurement of haemolysis markers following transfusion of uncrossmatched, low‐titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre , 2017, Transfusion medicine.
[5] P. Spinella,et al. Whole blood: back to the future. , 2016, Current opinion in hematology.
[6] J. Sperry,et al. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients , 2016, The journal of trauma and acute care surgery.
[7] D. Triulzi,et al. Whole blood for the acutely haemorrhaging civilian trauma patient: a novel idea or rediscovery? , 2016, Transfusion medicine.
[8] T. Hervig,et al. Whole blood for hemostatic resuscitation of major bleeding , 2016, Transfusion.
[9] J. Sperry,et al. The effect of stationary versus rocked storage of whole blood on red blood cell damage and platelet function , 2016, Transfusion.
[10] T. Hervig,et al. Low Titer Group O Whole Blood in Emergency Situations , 2014, Shock.
[11] D. Jenkins,et al. Back to the future: the renaissance of whole-blood transfusions for massively hemorrhaging patients. , 2014, Surgery.
[12] Jorge Lazareff,et al. How I Do It , 2014, Surgical Neurology International.
[13] C. Wade,et al. A Randomized Controlled Pilot Trial of Modified Whole Blood versus Component Therapy in Severely Injured Patients Requiring Large Volume Transfusions , 2013, Annals of surgery.
[14] J. Cid,et al. Platelet Transfusion - the Art and Science of Compromise , 2013, Transfusion Medicine and Hemotherapy.
[15] Shawn C. Nessen,et al. Risks of hemolysis due to anti‐A and anti‐B caused by the transfusion of blood or blood components containing ABO‐incompatible plasma , 2013, Transfusion.
[16] Shilpi Gupta,et al. Clinical Usefulness of Haptoglobin Levels to Evaluate Hemolysis in Recently Transfused Patients , 2011, Advances in hematology.
[17] W. Flegel,et al. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high‐titer ABO antibodies , 2011, Transfusion.
[18] P. Scheinberg,et al. Probiotic‐associated high‐titer anti‐B in a group A platelet donor as a cause of severe hemolytic transfusion reactions , 2009, Transfusion.
[19] L. Cooling. ABO and platelet transfusion therapy , 2007, Immunohematology.
[20] R. Malthaner,et al. Hemolysis with rapid transfusion systems in the trauma setting. , 2004, Canadian journal of surgery. Journal canadien de chirurgie.
[21] Laurence Klotz. Reactions , 2002, The Lancet.
[22] M. Ellis,et al. The effect of external pressure, catheter gauge, andstorage time on hemolysis in RBC transfusion , 2001, Transfusion.
[23] K. Hanaoka,et al. Free hemoglobin concentrations in patients receiving massive blood transfusion during emergency surgery for trauma , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[24] L. Larsson,et al. Acute intravascular hemolysis secondaryto out‐of‐group platelet transfusion , 2000, Transfusion.
[25] A. Barnes. Transfusion of universal donor and uncrossmatched blood. , 1980, Bibliotheca haematologica.
[26] W. Haddon,et al. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. , 1974, The Journal of trauma.
[27] L. Petz,et al. Serum haptoglobin. A valuable diagnostic aid in suspected hemolytic transfusion reactions. , 1967, JAMA.
[28] Standards for blood banks and transfusion services. , 1977, QRB. Quality review bulletin.